Literature DB >> 12818177

Control of synaptic strength, a novel function of Akt.

Qinghua Wang1, Lidong Liu, Lin Pei, William Ju, Gholamreza Ahmadian, Jie Lu, Yushan Wang, Fang Liu, Yu Tian Wang.   

Abstract

Akt (also known as PKB), a serine/threonine kinase involved in diverse signal-transduction pathways, is highly expressed in the brain. Akt is known to have a strong antiapoptotic action and thereby to be critically involved in neuronal survival, but its potential role in the dynamic modulation of synaptic transmission is unknown. Here we report that Akt phosphorylates, both in vitro and in vivo, the type A gamma-aminobutyric acid receptor (GABA(A)R), the principal receptor mediating fast inhibitory synaptic transmission in the mammalian brain. Akt-mediated phosphorylation increases the number of GABA(A)Rs on the plasma membrane surface, thereby increasing the receptor-mediated synaptic transmission in neurons. These results identify the GABA(A)R as a novel substrate of Akt, thereby linking Akt to the regulation of synaptic strength. This work also provides evidence for the rapid regulation of neurotransmitter receptor numbers in the postsynaptic domain by direct receptor phosphorylation as an important means of producing synaptic plasticity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12818177     DOI: 10.1016/s0896-6273(03)00356-8

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  93 in total

1.  NMDA receptors regulate GABAA receptor lateral mobility and clustering at inhibitory synapses through serine 327 on the γ2 subunit.

Authors:  James Muir; I Lorena Arancibia-Carcamo; Andrew F MacAskill; Katharine R Smith; Lewis D Griffin; Josef T Kittler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-07       Impact factor: 11.205

Review 2.  Sources and targets of reactive oxygen species in synaptic plasticity and memory.

Authors:  Kenneth T Kishida; Eric Klann
Journal:  Antioxid Redox Signal       Date:  2007-02       Impact factor: 8.401

Review 3.  Aspects of the homeostaic plasticity of GABAA receptor-mediated inhibition.

Authors:  Istvan Mody
Journal:  J Physiol       Date:  2004-11-04       Impact factor: 5.182

4.  Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus.

Authors:  David E Naylor; Hantao Liu; Claude G Wasterlain
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

5.  Quantitative trait loci linked to thalamus and cortex gray matter volumes in BXD recombinant inbred mice.

Authors:  H Dong; M V Martin; J Colvin; Z Ali; L Wang; L Lu; R W Williams; G D Rosen; J G Csernansky; J M Cheverud
Journal:  Heredity (Edinb)       Date:  2007-04-04       Impact factor: 3.821

6.  Activity-dependent phosphorylation of GABAA receptors regulates receptor insertion and tonic current.

Authors:  Richard S Saliba; Karla Kretschmannova; Stephen J Moss
Journal:  EMBO J       Date:  2012-04-24       Impact factor: 11.598

7.  Delta-catenin-induced dendritic morphogenesis. An essential role of p190RhoGEF interaction through Akt1-mediated phosphorylation.

Authors:  Hangun Kim; Jeong-Ran Han; Jaejun Park; Minsoo Oh; Sarah E James; Sunghoe Chang; Qun Lu; Kwang Youl Lee; Hyunkyoung Ki; Woo-Joo Song; Kwonseop Kim
Journal:  J Biol Chem       Date:  2007-11-08       Impact factor: 5.157

8.  Subunit-specific trafficking of GABA(A) receptors during status epilepticus.

Authors:  Howard P Goodkin; Suchitra Joshi; Zakaria Mtchedlishvili; Jasmit Brar; Jaideep Kapur
Journal:  J Neurosci       Date:  2008-03-05       Impact factor: 6.167

9.  Freud-1/Aki1, a novel PDK1-interacting protein, functions as a scaffold to activate the PDK1/Akt pathway in epidermal growth factor signaling.

Authors:  Akito Nakamura; Mikihiko Naito; Takashi Tsuruo; Naoya Fujita
Journal:  Mol Cell Biol       Date:  2008-07-28       Impact factor: 4.272

10.  AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families.

Authors:  Dawn L Thiselton; Vladimir I Vladimirov; Po-Hsiu Kuo; Joseph McClay; Brandon Wormley; Ayman Fanous; Francis A O'Neill; Dermot Walsh; Edwin J C G Van den Oord; Kenneth S Kendler; Brien P Riley
Journal:  Biol Psychiatry       Date:  2007-09-06       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.